Lori Anne Kunkel - Insider Trading & Ownership

Location
C/O Pharmacyclics, Inc., 995 East Arques Avenue, Sunnyvale, CA
Summary
The estimated net worth of Lori Anne Kunkel is at least $2.31M dollars as of May 19, 2025. Lori Anne Kunkel is the Director of CURIS INC and owns shares of CURIS INC (CRIS) stock worth about $988K. Lori Anne Kunkel is the Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $891K. Lori Anne Kunkel is the Director of Oric Pharmaceuticals, Inc. and owns shares of Oric Pharmaceuticals, Inc. (ORIC) stock worth about $435K.
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Lori Ann Kunkel
All Insider Reports
All Insider Reports

Ownership of Lori Anne Kunkel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRIS CURIS INC Director $988K Jan 31, 2022
ELVN, IMRA Enliven Therapeutics, Inc. Director $891K Feb 6, 2025
ORIC Oric Pharmaceuticals, Inc. Director $435K Mar 3, 2025
NRIX Nurix Therapeutics, Inc. Director $0 May 19, 2025

Insider Transactions Reported by Lori Anne Kunkel:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.